0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Dermatology OTC Medications Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-3A16200
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and India Dermatology OTC Medications Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Dermatology OTC Medications Market Report & Forecast 2023-2029

Code: QYRE-Auto-3A16200
Report
November 2023
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Dermatology OTC Medications Market Size

The global Dermatology OTC Medications revenue was US$ 12780 million in 2022 and is forecast to a readjusted size of US$ 16080 million by 2029 with a CAGR of 3.3% during the forecast period (2023-2029).

and India Dermatology OTC Medications Market

and India Dermatology OTC Medications Market

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
In India, the Dermatology OTC Medications revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.
This report focuses on global and India Dermatology OTC Medications market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Dermatology OTC Medications will continue to grow rapidly in the future.
Global Dermatology OTC Medications Scope and Market Size
Dermatology OTC Medications market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Dermatology OTC Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Dermatology OTC Medications market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Dermatology OTC Medications Market Report

Report Metric Details
Report Name and India Dermatology OTC Medications Market
Forecasted market size in 2029 US$ 16080 million
CAGR 3.3%
Forecasted years 2023 - 2029
Segment by Type
  • External Use
  • Oral
Segment by Application
  • Hospital
  • Drug Store
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, Sun Pharmaceutical, Aurobindo, Galderma, CR SANJIU, Dr. Reddy's, Lupin, Bausch Health, Cipla, Qilu Pharmaceutical, Almirall, Lingrui
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Dermatology OTC Medications Market size in 2029?

Ans: The and India Dermatology OTC Medications Market size in 2029 will be US$ 16080 million.

What is the market share of major companies in and India Dermatology OTC Medications Market?

Ans: Top 5 manufacturers accounted for 25.08% market share in 2019.

What is the and India Dermatology OTC Medications Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Dermatology OTC Medications Market report?

Ans: The main players in the and India Dermatology OTC Medications Market are Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, Sun Pharmaceutical, Aurobindo, Galderma, CR SANJIU, Dr. Reddy's, Lupin, Bausch Health, Cipla, Qilu Pharmaceutical, Almirall, Lingrui

What are the Application segmentation covered in the and India Dermatology OTC Medications Market report?

Ans: The Applications covered in the and India Dermatology OTC Medications Market report are Hospital, Drug Store, Other

What are the Type segmentation covered in the and India Dermatology OTC Medications Market report?

Ans: The Types covered in the and India Dermatology OTC Medications Market report are External Use, Oral

1 Study Coverage
1.1 Dermatology OTC Medications Product Introduction
1.2 Global Dermatology OTC Medications Outlook 2018 VS 2022 VS 2029
1.2.1 Global Dermatology OTC Medications Sales in US$ Million for the Year 2018-2029
1.2.2 Global Dermatology OTC Medications Sales in Volume for the Year 2018-2029
1.3 India Dermatology OTC Medications Outlook 2018 VS 2022 VS 2029
1.3.1 India Dermatology OTC Medications Sales in US$ Million for the Year 2018-2029
1.3.2 India Dermatology OTC Medications Sales in Volume for the Year 2018-2029
1.4 Dermatology OTC Medications Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Dermatology OTC Medications in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Dermatology OTC Medications Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Dermatology OTC Medications Market Dynamics
1.5.1 Dermatology OTC Medications Industry Trends
1.5.2 Dermatology OTC Medications Market Drivers
1.5.3 Dermatology OTC Medications Market Challenges
1.5.4 Dermatology OTC Medications Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Dermatology OTC Medications by Type
2.1 Dermatology OTC Medications Market Segment by Type
2.1.1 External Use
2.1.2 Oral
2.2 Global Dermatology OTC Medications Market Size by Type
2.2.1 Global Dermatology OTC Medications Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Dermatology OTC Medications Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Dermatology OTC Medications Market Size by Type
2.3.1 India Dermatology OTC Medications Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Dermatology OTC Medications Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Dermatology OTC Medications Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Dermatology OTC Medications by Application
3.1 Dermatology OTC Medications Market Segment by Application
3.1.1 Hospital
3.1.2 Drug Store
3.1.3 Other
3.2 Global Dermatology OTC Medications Market Size by Application
3.2.1 Global Dermatology OTC Medications Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Dermatology OTC Medications Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Dermatology OTC Medications Market Size by Application
3.3.1 India Dermatology OTC Medications Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Dermatology OTC Medications Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Dermatology OTC Medications Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Dermatology OTC Medications Competitor Landscape by Company
4.1 Global Dermatology OTC Medications Market Size by Company
4.1.1 Global Key Manufacturers of Dermatology OTC Medications, Ranked by Revenue (2022)
4.1.2 Global Dermatology OTC Medications Revenue by Manufacturer (2018-2023)
4.1.3 Global Dermatology OTC Medications Sales by Manufacturer (2018-2023)
4.1.4 Global Dermatology OTC Medications Price by Manufacturer (2018-2023)
4.2 Global Dermatology OTC Medications Concentration Ratio (CR)
4.2.1 Dermatology OTC Medications Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dermatology OTC Medications in 2022
4.2.3 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Dermatology OTC Medications, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Dermatology OTC Medications, Product Offered and Application
4.5 Global Key Manufacturers of Dermatology OTC Medications, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Dermatology OTC Medications Market Size by Company
4.7.1 Key Players of Dermatology OTC Medications in India, Ranked by Revenue (2022)
4.7.2 India Dermatology OTC Medications Revenue by Players (2018-2023)
4.7.3 India Dermatology OTC Medications Sales by Players (2018-2023)
5 Global Dermatology OTC Medications Market Size by Region
5.1 Global Dermatology OTC Medications Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Dermatology OTC Medications Market Size in Volume by Region (2018-2029)
5.2.1 Global Dermatology OTC Medications Sales in Volume by Region: 2018-2023
5.2.2 Global Dermatology OTC Medications Sales in Volume Forecast by Region (2024-2029)
5.3 Global Dermatology OTC Medications Market Size in Value by Region (2018-2029)
5.3.1 Global Dermatology OTC Medications Sales in Value by Region: 2018-2023
5.3.2 Global Dermatology OTC Medications Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Dermatology OTC Medications Market Size YoY Growth 2018-2029
6.2 Americas Dermatology OTC Medications Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Dermatology OTC Medications Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Dermatology OTC Medications Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Dermatology OTC Medications Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Dermatology OTC Medications Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Dermatology OTC Medications Market Size YoY Growth 2018-2029
7.2 EMEA Dermatology OTC Medications Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Dermatology OTC Medications Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Dermatology OTC Medications Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Dermatology OTC Medications Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Dermatology OTC Medications Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Dermatology OTC Medications Market Size YoY Growth 2018-2029
8.2 China Dermatology OTC Medications Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Dermatology OTC Medications Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Dermatology OTC Medications Market Size YoY Growth 2018-2029
9.2 APAC Dermatology OTC Medications Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Dermatology OTC Medications Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Dermatology OTC Medications Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Dermatology OTC Medications Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Dermatology OTC Medications Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Description and Business Overview
10.1.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Dermatology OTC Medications Products Offered
10.1.5 Bayer Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Description and Business Overview
10.2.3 GSK Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Dermatology OTC Medications Products Offered
10.2.5 GSK Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Description and Business Overview
10.3.3 Teva Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Dermatology OTC Medications Products Offered
10.3.5 Teva Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Description and Business Overview
10.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Johnson & Johnson Dermatology OTC Medications Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Description and Business Overview
10.5.3 Novartis Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis Dermatology OTC Medications Products Offered
10.5.5 Novartis Recent Development
10.6 Mylan
10.6.1 Mylan Company Information
10.6.2 Mylan Description and Business Overview
10.6.3 Mylan Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mylan Dermatology OTC Medications Products Offered
10.6.5 Mylan Recent Development
10.7 Sun Pharmaceutical
10.7.1 Sun Pharmaceutical Company Information
10.7.2 Sun Pharmaceutical Description and Business Overview
10.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sun Pharmaceutical Dermatology OTC Medications Products Offered
10.7.5 Sun Pharmaceutical Recent Development
10.8 Aurobindo
10.8.1 Aurobindo Company Information
10.8.2 Aurobindo Description and Business Overview
10.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Aurobindo Dermatology OTC Medications Products Offered
10.8.5 Aurobindo Recent Development
10.9 Galderma
10.9.1 Galderma Company Information
10.9.2 Galderma Description and Business Overview
10.9.3 Galderma Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Galderma Dermatology OTC Medications Products Offered
10.9.5 Galderma Recent Development
10.10 CR SANJIU
10.10.1 CR SANJIU Company Information
10.10.2 CR SANJIU Description and Business Overview
10.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CR SANJIU Dermatology OTC Medications Products Offered
10.10.5 CR SANJIU Recent Development
10.11 Dr. Reddy's
10.11.1 Dr. Reddy's Company Information
10.11.2 Dr. Reddy's Description and Business Overview
10.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Dr. Reddy's Dermatology OTC Medications Products Offered
10.11.5 Dr. Reddy's Recent Development
10.12 Lupin
10.12.1 Lupin Company Information
10.12.2 Lupin Description and Business Overview
10.12.3 Lupin Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Lupin Dermatology OTC Medications Products Offered
10.12.5 Lupin Recent Development
10.13 Bausch Health
10.13.1 Bausch Health Company Information
10.13.2 Bausch Health Description and Business Overview
10.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Bausch Health Dermatology OTC Medications Products Offered
10.13.5 Bausch Health Recent Development
10.14 Cipla
10.14.1 Cipla Company Information
10.14.2 Cipla Description and Business Overview
10.14.3 Cipla Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Cipla Dermatology OTC Medications Products Offered
10.14.5 Cipla Recent Development
10.15 Qilu Pharmaceutical
10.15.1 Qilu Pharmaceutical Company Information
10.15.2 Qilu Pharmaceutical Description and Business Overview
10.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Qilu Pharmaceutical Dermatology OTC Medications Products Offered
10.15.5 Qilu Pharmaceutical Recent Development
10.16 Almirall
10.16.1 Almirall Company Information
10.16.2 Almirall Description and Business Overview
10.16.3 Almirall Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Almirall Dermatology OTC Medications Products Offered
10.16.5 Almirall Recent Development
10.17 Lingrui
10.17.1 Lingrui Company Information
10.17.2 Lingrui Description and Business Overview
10.17.3 Lingrui Dermatology OTC Medications Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Lingrui Dermatology OTC Medications Products Offered
10.17.5 Lingrui Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Dermatology OTC Medications Industry Chain Analysis
11.2 Dermatology OTC Medications Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Dermatology OTC Medications Production Mode & Process
11.4 Dermatology OTC Medications Sales and Marketing
11.4.1 Dermatology OTC Medications Sales Channels
11.4.2 Dermatology OTC Medications Distributors
11.5 Dermatology OTC Medications Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Dermatology OTC Medications CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Dermatology OTC Medications Market Trends
    Table 3. Dermatology OTC Medications Market Drivers
    Table 4. Dermatology OTC Medications Market Challenges
    Table 5. Dermatology OTC Medications Market Restraints
    Table 6. Global Dermatology OTC Medications Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Dermatology OTC Medications Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Dermatology OTC Medications Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Dermatology OTC Medications Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Dermatology OTC Medications, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Dermatology OTC Medications Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Dermatology OTC Medications Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Dermatology OTC Medications Sales by Manufacturer, (M Units), 2018-2023
    Table 14. Global Dermatology OTC Medications Sales Share by Manufacturer, 2018-2023
    Table 15. Global Dermatology OTC Medications Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 16. Global Dermatology OTC Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Dermatology OTC Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2022)
    Table 18. Global Key Manufacturers of Dermatology OTC Medications, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Dermatology OTC Medications, Product Offered and Application
    Table 20. Global Key Manufacturers of Dermatology OTC Medications, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Dermatology OTC Medications in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Dermatology OTC Medications Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Dermatology OTC Medications Revenue Share by Players, (2018-2023)
    Table 25. India Dermatology OTC Medications Sales by Players, (M Units), (2018-2023)
    Table 26. India Dermatology OTC Medications Sales Share by Players, (2018-2023)
    Table 27. Global Dermatology OTC Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Dermatology OTC Medications Sales in Volume by Region (2018-2023) & (M Units)
    Table 29. Global Dermatology OTC Medications Sales in Volume Forecast by Region (2024-2029) & (M Units)
    Table 30. Global Dermatology OTC Medications Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Dermatology OTC Medications Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Dermatology OTC Medications Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Dermatology OTC Medications Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Dermatology OTC Medications Sales in Volume by Country (2018-2023) & (M Units)
    Table 36. Americas Dermatology OTC Medications Sales in Volume by Country (2024-2029) & (M Units)
    Table 37. EMEA Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Dermatology OTC Medications Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Dermatology OTC Medications Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Dermatology OTC Medications Sales in Volume by Country (2018-2023) & (M Units)
    Table 41. EMEA Dermatology OTC Medications Sales in Volume by Country (2024-2029) & (M Units)
    Table 42. APAC Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Dermatology OTC Medications Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Dermatology OTC Medications Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Dermatology OTC Medications Sales in Volume by Country (2018-2023) & (M Units)
    Table 46. APAC Dermatology OTC Medications Sales in Volume by Country (2024-2029) & (M Units)
    Table 47. Bayer Company Information
    Table 48. Bayer Description and Business Overview
    Table 49. Bayer Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 50. Bayer Dermatology OTC Medications Product
    Table 51. Bayer Recent Development
    Table 52. GSK Company Information
    Table 53. GSK Description and Business Overview
    Table 54. GSK Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 55. GSK Dermatology OTC Medications Product
    Table 56. GSK Recent Development
    Table 57. Teva Company Information
    Table 58. Teva Description and Business Overview
    Table 59. Teva Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 60. Teva Dermatology OTC Medications Product
    Table 61. Teva Recent Development
    Table 62. Johnson & Johnson Company Information
    Table 63. Johnson & Johnson Description and Business Overview
    Table 64. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 65. Johnson & Johnson Dermatology OTC Medications Product
    Table 66. Johnson & Johnson Recent Development
    Table 67. Novartis Company Information
    Table 68. Novartis Description and Business Overview
    Table 69. Novartis Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 70. Novartis Dermatology OTC Medications Product
    Table 71. Novartis Recent Development
    Table 72. Mylan Company Information
    Table 73. Mylan Description and Business Overview
    Table 74. Mylan Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 75. Mylan Dermatology OTC Medications Product
    Table 76. Mylan Recent Development
    Table 77. Sun Pharmaceutical Company Information
    Table 78. Sun Pharmaceutical Description and Business Overview
    Table 79. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 80. Sun Pharmaceutical Dermatology OTC Medications Product
    Table 81. Sun Pharmaceutical Recent Development
    Table 82. Aurobindo Company Information
    Table 83. Aurobindo Description and Business Overview
    Table 84. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 85. Aurobindo Dermatology OTC Medications Product
    Table 86. Aurobindo Recent Development
    Table 87. Galderma Company Information
    Table 88. Galderma Description and Business Overview
    Table 89. Galderma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 90. Galderma Dermatology OTC Medications Product
    Table 91. Galderma Recent Development
    Table 92. CR SANJIU Company Information
    Table 93. CR SANJIU Description and Business Overview
    Table 94. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 95. CR SANJIU Dermatology OTC Medications Product
    Table 96. CR SANJIU Recent Development
    Table 97. Dr. Reddy's Company Information
    Table 98. Dr. Reddy's Description and Business Overview
    Table 99. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 100. Dr. Reddy's Dermatology OTC Medications Product
    Table 101. Dr. Reddy's Recent Development
    Table 102. Lupin Company Information
    Table 103. Lupin Description and Business Overview
    Table 104. Lupin Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 105. Lupin Dermatology OTC Medications Product
    Table 106. Lupin Recent Development
    Table 107. Bausch Health Company Information
    Table 108. Bausch Health Description and Business Overview
    Table 109. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 110. Bausch Health Dermatology OTC Medications Product
    Table 111. Bausch Health Recent Development
    Table 112. Cipla Company Information
    Table 113. Cipla Description and Business Overview
    Table 114. Cipla Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 115. Cipla Dermatology OTC Medications Product
    Table 116. Cipla Recent Development
    Table 117. Qilu Pharmaceutical Company Information
    Table 118. Qilu Pharmaceutical Description and Business Overview
    Table 119. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 120. Qilu Pharmaceutical Dermatology OTC Medications Product
    Table 121. Qilu Pharmaceutical Recent Development
    Table 122. Almirall Company Information
    Table 123. Almirall Description and Business Overview
    Table 124. Almirall Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 125. Almirall Dermatology OTC Medications Product
    Table 126. Almirall Recent Development
    Table 127. Lingrui Company Information
    Table 128. Lingrui Description and Business Overview
    Table 129. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 130. Lingrui Dermatology OTC Medications Product
    Table 131. Lingrui Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Dermatology OTC Medications Customers List
    Table 135. Dermatology OTC Medications Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dermatology OTC Medications Product Picture
    Figure 2. Global Dermatology OTC Medications Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Dermatology OTC Medications Market Size 2018-2029 (US$ Million)
    Figure 4. Global Dermatology OTC Medications Sales 2018-2029 (M Units)
    Figure 5. India Dermatology OTC Medications Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Dermatology OTC Medications Market Size 2018-2029 (US$ Million)
    Figure 7. India Dermatology OTC Medications Sales 2018-2029 (M Units)
    Figure 8. India Dermatology OTC Medications Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Dermatology OTC Medications Market Share in Global, in Volume (M Units) 2018-2029
    Figure 10. Dermatology OTC Medications Report Years Considered
    Figure 11. Product Picture of External Use
    Figure 12. Product Picture of Oral
    Figure 13. Global Dermatology OTC Medications Market Share by Type in 2022 & 2029
    Figure 14. Global Dermatology OTC Medications Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 15. Global Dermatology OTC Medications Sales Market Share in Value by Type (2018-2029)
    Figure 16. Global Dermatology OTC Medications Sales by Type (2018-2029) & (M Units)
    Figure 17. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2018-2029)
    Figure 18. Global Dermatology OTC Medications Price by Type (2018-2029) & (USD/Unit)
    Figure 19. India Dermatology OTC Medications Market Share by Type in 2022 & 2029
    Figure 20. India Dermatology OTC Medications Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 21. India Dermatology OTC Medications Sales Market Share in Value by Type (2018-2029)
    Figure 22. India Dermatology OTC Medications Sales by Type (2018-2029) & (M Units)
    Figure 23. India Dermatology OTC Medications Sales Market Share in Volume by Type (2018-2029)
    Figure 24. India Dermatology OTC Medications Price by Type (2018-2029) & (USD/Unit)
    Figure 25. Product Picture of Hospital
    Figure 26. Product Picture of Drug Store
    Figure 27. Product Picture of Other
    Figure 28. Global Dermatology OTC Medications Market Share by Application in 2022 & 2029
    Figure 29. Global Dermatology OTC Medications Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 30. Global Dermatology OTC Medications Sales Market Share in Value by Application (2018-2029)
    Figure 31. Global Dermatology OTC Medications Sales by Application (2018-2029) & (M Units)
    Figure 32. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2018-2029)
    Figure 33. Global Dermatology OTC Medications Price by Application (2018-2029) & (USD/Unit)
    Figure 34. India Dermatology OTC Medications Market Share by Application in 2022 & 2029
    Figure 35. India Dermatology OTC Medications Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 36. India Dermatology OTC Medications Sales Market Share in Value by Application (2018-2029)
    Figure 37. India Dermatology OTC Medications Sales by Application (2018-2029) & (M Units)
    Figure 38. India Dermatology OTC Medications Sales Market Share in Volume by Application (2018-2029)
    Figure 39. India Dermatology OTC Medications Price by Application (2018-2029) & (USD/Unit)
    Figure 40. Americas Dermatology OTC Medications Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 41. Americas Dermatology OTC Medications Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 42. Americas Dermatology OTC Medications Sales by Type (2018-2029) & (M Units)
    Figure 43. Americas Dermatology OTC Medications Sales Market Share in Volume by Type (2018-2029)
    Figure 44. Americas Dermatology OTC Medications Sales by Application (2018-2029) & (M Units)
    Figure 45. Americas Dermatology OTC Medications Sales Market Share in Volume by Application (2018-2029)
    Figure 46. United States Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Canada Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Mexico Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. EMEA Dermatology OTC Medications Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 51. EMEA Dermatology OTC Medications Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 52. EMEA Dermatology OTC Medications Sales by Type (2018-2029) & (M Units)
    Figure 53. EMEA Dermatology OTC Medications Sales Market Share in Volume by Type (2018-2029)
    Figure 54. EMEA Dermatology OTC Medications Sales by Application (2018-2029) & (M Units)
    Figure 55. EMEA Dermatology OTC Medications Sales Market Share in Volume by Application (2018-2029)
    Figure 56. Europe Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Middle East Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Africa Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. China Dermatology OTC Medications Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 60. China Dermatology OTC Medications Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 61. China Dermatology OTC Medications Sales by Type (2018-2029) & (M Units)
    Figure 62. China Dermatology OTC Medications Sales Market Share in Volume by Type (2018-2029)
    Figure 63. China Dermatology OTC Medications Sales by Application (2018-2029) & (M Units)
    Figure 64. China Dermatology OTC Medications Sales Market Share in Volume by Application (2018-2029)
    Figure 65. APAC Dermatology OTC Medications Sales in Volume Growth Rate 2018-2029 (M Units)
    Figure 66. APAC Dermatology OTC Medications Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 67. APAC Dermatology OTC Medications Sales by Type (2018-2029) & (M Units)
    Figure 68. APAC Dermatology OTC Medications Sales Market Share in Volume by Type (2018-2029)
    Figure 69. APAC Dermatology OTC Medications Sales by Application (2018-2029) & (M Units)
    Figure 70. APAC Dermatology OTC Medications Sales Market Share in Volume by Application (2018-2029)
    Figure 71. Japan Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 72. South Korea Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. China Taiwan Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. Southeast Asia Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. India Dermatology OTC Medications Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Dermatology OTC Medications Value Chain
    Figure 77. Dermatology OTC Medications Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS